Validity of Stroke Diagnoses in a National Register of PatientsKrarup L.-H.a · Boysen G.a · Janjua H.a · Prescott E.b · Truelsen T.a
aDepartment of Neurology, Copenhagen University Hospital Bispebjerg, and bDanish Epidemiology Science Center at the Institute of Preventive Medicine of Copenhagen, Copenhagen, Denmark
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Many registers containing routine medical information have been developed for research and surveillance purposes. In epidemiological research assessment of endpoints is often conducted via registers. In the present study we validated stroke and transient ischemic attack (TIA) diagnoses in the Danish National Register of Patients (DNRP). Methods: Subjects from a Danish cohort study, the Copenhagen City Heart Study (n = 19,698), were crosslinked with the DNRP. The following International Classification of Disease 10th revision codes were used to identify possible strokes and TIAs: I60–I69 and G45. Two independent raters reviewed all cases. Positive predictive values of stroke, TIA and stroke subtypes were estimated by dividing the confirmed cases by the total number of cases located in the DNRP. Interrater reliability was tested using ĸ statistics. Results: Of 236 possible cerebrovascular events, 1 in 6 stroke diagnoses did not meet study criteria. The majority of events in the DNRP were registered as unspecified stroke (I64), n = 105 (44%), of which two thirds were diagnosed as ischemic stroke events by the raters. Intracerebral hemorrhage and ischemic stroke had a positive predictive value from 74 to 97%, respectively. Conclusion: Our results show that the DNRP tends to overestimate the number of cerebrovascular events, while ischemic stroke is underestimated.
© 2007 S. Karger AG, Basel
- Stegmayr B, Asplund K: Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. Neuroepidemiology 1992;11:204–213.
- Leppala JM, Virtamo J, Heinonen OP: Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. Eur J Epidemiol 1999;15:155–160.
- Ellekjaer H, Holmen J, Kruger O, Terent A: Identification of incident stroke in Norway: hospital discharge data compared with a population-based stroke register. Stroke 1999;30:56–60.
- Johnsen SP, Overvad K, Sorensen HT, Tjonneland A, Husted SE: Predictive value of stroke and transient ischemic attack discharge diagnoses in The Danish National Registry of Patients. J Clin Epidemiol 2002;55:602–607.
- Liu L, Reeder B, Shuaib A, Mazagri R: Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: implications for stroke surveillance. Cerebrovasc Dis 1999;9:224–230.
- Leibson CL, Naessens JM, Brown RD, Whisnant JP: Accuracy of hospital discharge abstracts for identifying stroke. Stroke 1994;25:2348–2355.
- Mahonen M, Salomaa V, Keskimaki I, Moltchanov V, Torppa J, Molarius A, Tuomilehto J, Sarti C: The feasibility of combining data from routine Hospital Discharge and Causes-of-Death Registers for epidemiological studies on stroke. Eur J Epidemiol 2000;16:815–817.
- Spolaore P, Brocco S, Fedeli U, Visentin C, Schievano E, Avossa F, Milan G, Toso V, Vanuzzo D, Pilotto L, Pessina AC, Bonita R: Measuring accuracy of discharge diagnoses for a region-wide surveillance of hospitalized strokes. Stroke 2005;36:1031–1034.
Appleyard M HT, Schnohr P, Jensen G, Nyboe J: The Copenhagen City Heart Study: Østerbroundersøgelsen – A book of tables with data from the first examination (1976–78) and a five-year follow-up (1981–1983). Scand J Soc Med 1989;170:1–160.
- Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH: The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull 1999;46:263–268.
- WHO MONICA Project Principal Investigators: The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105–114.
- Lindgren A, Norrving B, Rudling O, Johansson BB: Comparison of clinical and neuroradiological findings in first-ever stroke: a population-based study. Stroke 1994;25:1371–1377.
A Classification and Outline of Cerebrovascular Diseases II. Stroke 1975;6:564–616.
Olsen J: Measurement techniques; in: Headache Classification and Epidemiology. Frontiers in Headache Research. New York, Raven Press, 1994.
- Fleiss JL, Cohen J, Everitt BS: Large sample standard errors of kappa and weighted kappa. Psychol Bull 1969;72:323–327.
Fleiss JL: Statistical Methods for Rates and Proportion. New York, Wiley, 1981.
- Chmura Kraemer H, Periyakoil VS, Noda A: Kappa coefficients in medical research. Stat Med 2002;21:2109–2129.
- Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159–174.
- Feigin VL, Lawes CM, Bennett DA, Anderson CS: Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43–53.
- Lindley RI, Warlow CP, Wardlaw JM, Dennis MS, Slattery J, Sandercock PA: Interobserver reliability of a clinical classification of acute cerebral infarction. Stroke 1993;24:1801–1804.
- Sorensen HT, Sabroe S, Olsen J: A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol 1996;25:435–442.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.